A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
A phase 1/2 trial of CTX112 in hodgkin lymphoma and non-hodgkin lymphoma, run by CRISPR Therapeutics AG, now recruiting.
Overview
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies is a phase 1/2 interventional study registered as NCT05643742 by CRISPR Therapeutics AG, with 120 participants planned, started 2023-03-10 and due to reach its primary completion in 2030-01. Interventions recorded: CTX112. Conditions listed: B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy, Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL). No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialTreatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
Shares Mantle cell lymphoma, Follicular lymphoma, Non-Hodgkin lymphoma (all types), Hodgkin lymphoma.
- TrialA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Shares Mantle cell lymphoma, Follicular lymphoma, Non-Hodgkin lymphoma (all types), Hodgkin lymphoma.
- TrialGene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Shares Mantle cell lymphoma, Follicular lymphoma, Non-Hodgkin lymphoma (all types).
- TrialSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Shares Follicular lymphoma, Non-Hodgkin lymphoma (all types), Hodgkin lymphoma.
- TermLugano classification / Ann Arbor staging
Shares Mantle cell lymphoma, Follicular lymphoma, Hodgkin lymphoma.
- CollectionLymphoma Research Foundation (LRF)
Shares Mantle cell lymphoma, Follicular lymphoma, Hodgkin lymphoma.
- TrialT-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
- TrialA Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantl
Shares Mantle cell lymphoma, Non-Hodgkin lymphoma (all types), Hodgkin lymphoma.